de Koning I - Search Results

1

The CAMCOG: a useful screening instrument for dementia in stroke patients.

de Koning I, van Kooten F, Dippel DW, van Harskamp F, Grobbee DE, Kluft C, Koudstaal PJ. de Koning I, et al. Stroke. 1998 Oct;29(10):2080-6. doi: 10.1161/01.str.29.10.2080. Stroke. 1998. PMID: 9756586 Free article.

2

Value of screening instruments in the diagnosis of post-stroke dementia.

de Koning I, van Kooten F, Koudstaal PJ. de Koning I, et al. Haemostasis. 1998 May-Aug;28(3-4):158-66. doi: 10.1159/000022427. Haemostasis. 1998. PMID: 10420063 Review.

3

A short screening instrument for poststroke dementia : the R-CAMCOG.

de Koning I, Dippel DW, van Kooten F, Koudstaal PJ. de Koning I, et al. Stroke. 2000 Jul;31(7):1502-8. doi: 10.1161/01.str.31.7.1502. Stroke. 2000. PMID: 10884444

4

Diagnostic value of the Rotterdam-CAMCOG in post-stroke dementia.

de Koning I, van Kooten F, Koudstaal PJ, Dippel DW. de Koning I, et al. J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):263-5. doi: 10.1136/jnnp.2004.039511. J Neurol Neurosurg Psychiatry. 2005. PMID: 15654047 Free PMC article.

5

The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study.

Claus JJ, van Harskamp F, Breteler MM, Krenning EP, de Koning I, van der Cammen TJ, Hofman A, Hasan D. Claus JJ, et al. Among authors: de koning i. Neurology. 1994 Mar;44(3 Pt 1):454-61. doi: 10.1212/wnl.44.3_part_1.454. Neurology. 1994. PMID: 8145915

6

Lisuride treatment of Alzheimer's disease. A preliminary placebo-controlled clinical trial of safety and therapeutic efficacy.

Claus JJ, de Koning I, van Harskamp F, Breteler MM, Voet B, Gutzmann H, Dahlke F, van der Cammen T, Hofman A. Claus JJ, et al. Among authors: de koning i. Clin Neuropharmacol. 1998 May-Jun;21(3):190-5. Clin Neuropharmacol. 1998. PMID: 9617511 Clinical Trial.

7

Abnormal amino acid metabolism in patients with early stage Alzheimer dementia.

Fekkes D, van der Cammen TJ, van Loon CP, Verschoor C, van Harskamp F, de Koning I, Schudel WJ, Pepplinkhuizen L. Fekkes D, et al. Among authors: de koning i. J Neural Transm (Vienna). 1998;105(2-3):287-94. doi: 10.1007/s007020050058. J Neural Transm (Vienna). 1998. PMID: 9660107 Free article. Clinical Trial.

8

Risk of left ventricular dysfunction in patients with probable Alzheimer's disease with APOE*4 allele.

van der Cammen TJ, Verschoor CJ, van Loon CP, van Harskamp F, de Koning I, Schudel WJ, Slooter AJ, Van Broeckhoven C, van Duijn CM. van der Cammen TJ, et al. Among authors: de koning i. J Am Geriatr Soc. 1998 Aug;46(8):962-7. doi: 10.1111/j.1532-5415.1998.tb02749.x. J Am Geriatr Soc. 1998. PMID: 9706883

9

Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692).

Roks G, Van Harskamp F, De Koning I, Cruts M, De Jonghe C, Kumar-Singh S, Tibben A, Tanghe H, Niermeijer MF, Hofman A, Van Swieten JC, Van Broeckhoven C, Van Duijn CM. Roks G, et al. Among authors: de jonghe c, de koning i. Brain. 2000 Oct;123 ( Pt 10):2130-40. doi: 10.1093/brain/123.10.2130. Brain. 2000. PMID: 11004129 Free article.

10

Frontotemporal dementia and neuropsychology: the value of missing values.

Smeding HM, de Koning I. Smeding HM, et al. Among authors: de koning i. J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):726-30. doi: 10.1136/jnnp.68.6.726. J Neurol Neurosurg Psychiatry. 2000. PMID: 10811695 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters